Wenli Gu

机构：Queen Mary Hospital, University of Hong Kong

发表论文 6 篇 · 总被引 2 次 · h-index 1

代表论文

• Sweet relief: exploring mechanisms and therapeutic approaches of sodium-glucose cotransporter-2 inhibitors in cardiovascular-kidney metabolic syndrome (2026 · Cardiovascular Diabetology · 被引 2)
• Hepatic Fibro-Inflammation and Atrial Fibrillation: A Dual-Track Metabolic Axis Revealed by a Metabolomic Clock (2026 · medRxiv)
• Additional file 1 of Sweet relief: exploring mechanisms and therapeutic approaches of sodium-glucose cotransporter-2 inhibitors in cardiovascular-kidney metabolic syndrome (2026 · Figshare)
• Additional file 1 of Sweet relief: exploring mechanisms and therapeutic approaches of sodium-glucose cotransporter-2 inhibitors in cardiovascular-kidney metabolic syndrome (2026 · Figshare)
• The predictive value of glycated albumin and hemoglobin A1c for all-cause and cardiovascular mortality in chronic kidney disease patients (2026 · Diabetology & Metabolic Syndrome)
• Metformin: A Promising Candidate for Slowing the Progression of Cardiovascular Aging (2026 · Aging and Disease)